| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.73 | 0.005 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.49 | 0.1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.4 | 0.2 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.25 | 0.04 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.25 | 0.009 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.23 | 0.07 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.21 | 0.0002 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.18 | 4e-06 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.05 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.006 |